FEATURED NEWS

• HDA 2018 DIANA Awards Honor Manufacturers for Industry Excellence

  June 12, 2018

  The Healthcare Distribution Alliance (HDA) honored pharmaceutical and consumer product manufacturers with the annual Distribution Industry Awards for Notable Achievements in Healthcare (DIANA). The awards were distributed at the HDA 2018 Business and Leadership Conference in Colorado Springs, Colo.

• Michael A. Conley of Novartis Pharmaceuticals Recognized with 2018 Nexus Award for Lifetime Achievement

  June 12, 2018

  The HDA Research Foundation, the non-profit organization of the Healthcare Distribution Alliance (HDA), recognized Michael A. Conley of Novartis Pharmaceuticals Corporation with the 2018 Nexus Award for Lifetime Achievement at the HDA Business and Leadership Conference in Colorado Springs. The award is made possible through the support of Genentech, A Member of the Roche Group, and Mylan Inc.

• Americares Honors Mylan with Power of Partnership Award

  June 11, 2018

  Americares, in partnership with the Healthcare Distribution Alliance (HDA), has presented its annual Power of Partnership Award to Mylan, in recognition of its outstanding commitment to increasing access to healthcare around the world. Mylan is among Americares most dedicated and longstanding supporters, providing pharmaceutical products for the organization’s health programs for people affected by poverty or disaster.

• HDA's Pharmaceutical Cargo Security Coalition Recognizes Leaders for Commitment to a Safe and Secure Supply Chain

  May 16, 2018

  HDA’s Pharmaceutical Cargo Security Coalition (PCSC) presented three awards at its educational seminar in East Hanover, New Jersey. Presented annually, the PCSC Award recognizes leaders who have exhibited extraordinary standards of honesty and integrity while working tirelessly to protect and serve their communities.

• HDA Statement on Enhanced Information Sharing Between DEA and Attorneys General

  April 18, 2018

  Healthcare Distribution Alliance (HDA) President and CEO John M. Gray welcomed Attorney General Jeff Sessions’ announcement yesterday of a prescription drug information-sharing agreement between the Drug Enforcement Administration (DEA) and the attorneys general of 46 states, the District of Columbia and Puerto Rico. Through this agreement, the DEA will share information from its Automation of Reports and Consolidated Orders System (ARCOS), with states providing the Agency additional information, “often from prescription drug monitoring programs (PDMPs).”